ECM
CINC

ExodusPoint Capital Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

ExodusPoint Capital Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,125
Closed -$161K – 2238
2022
Q4 		$161K Buy
+13,125
New +$313K ﹤0.01% 1484

ExodusPoint Capital Management's CINC Position: Q1 2023 in Review

ExodusPoint Capital Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 13,125 shares — an estimated $161K sold.

ExodusPoint Capital Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $161K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • ExodusPoint Capital Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 13,125 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $161K.
  • ExodusPoint Capital Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • ExodusPoint Capital Management's CinCor Pharma, Inc. Common Stock position peaked at $161K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on ExodusPoint Capital Management's 13F filing for Q1 2023, filed 11 May 2023.